Also from this source

You just read:

Sound Pharmaceuticals submits positive Phase 2 clinical trial data on SPI-1005 for the prevention and treatment of sensorineural hearing loss

News provided by

Sound Pharmaceuticals

Feb 18, 2014, 09:00 EST